You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Hormone Therapy and Stroke

BIRGE, STANLEY J. MD

Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e318181df30
Evidence-Based Approach to Menopause
Abstract

Available biochemical and clinical data are sufficiently compelling to recommend low dose or transdermal hormone therapy for the management of menopausal symptoms when possible. Women initiating low dose or transdermal hormone therapy are not at increased risk of cardiovascular disease, stroke, venous thrombotic disease, and breast cancer. Evidence suggests that these outcomes are favorably affected by low-dose hormone therapy and persist with continuation of therapy.

Author Information

Division of Geriatrics and Nutritional Science, Washington University School of Medicine, St Louis, Missouri

Correspondence: Stanley J. Birge, MD, Division of Geriatrics and Nutritional Science, Washington University School of Medicine, 4488 Forest Park Blvd, St Louis, MO 63108. E-mail: SBirge@DOM.wustl.edu

© 2008 Lippincott Williams & Wilkins, Inc.